Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
What did activate this to run yesterday and what did slow it down today? No news, no earnings?
Next should be a good positive news and it'll take off!
This is a good relief I think.
San Diego, California, March 19, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), an ocular health sciences company that, among other things, develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols, and provides ocular testing, announced today that it received a letter from the Listing Qualifications Department of The NASDAQ Capital Market (“Nasdaq”) notifying the Company that it has been granted an additional 180-day compliance period or until September 14, 2020, to regain compliance with the minimum $1.00 bid price per share requirement of Nasdaq's Marketplace Rule 5550(a)(2) (the “Rule”).
If at any time before September 14, 2020, the bid price of the Company's common stock closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Rule, and the matter will be closed. The letter indicated that the Company did not regain compliance during the initial 180-day grace period provided under the rule. In accordance with NASDAQ Marketplace Rule 5810(c)(3)(A), Nasdaq staff determined that the Company was eligible for an additional 180-day period to regain compliance based on the Company meeting the continued listing requirement for the market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq Capital Market with the exception of the bid price requirement, and the Company’s having provided written notice of its intention to cure the deficiency during the second compliance period, including effecting a reverse stock split if necessary.
If the Company does not meet the minimum bid requirement during the additional 180-day grace period, Nasdaq will provide written notification to the Company that its shares will be subject to delisting. At such time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel. The Company would remain listed pending the Panel's decision. There can be no assurance that if the Company does appeal a subsequent delisting determination, that such appeal would be successful.
This current notification from Nasdaq has no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq Capital Market under the symbol “GHSI.”
Did they announce the earnings?
News out Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
About to TAKEOFF zzzz
Looking good, still waiting for news let’s GO $GHSI$
Sure, my pleasure.
The main equities trading floor will shut down at 5:30 p.m. on Wednesday for additional sanitization after two people tested positive for the coronavirus as part of the exchange's medical screening, Cunningham said.
"We have been informed that a member of the trading floor community and a NYSE employee have tested positive for COVID-19," said Michael Blaugrund, the NYSE's chief operating officer. "Both individuals were screened at the NYSE security checkpoint, administered a test by medical personnel at the Exchange and, as a precautionary measure, not permitted to enter the building this week. They will be treated and recuperate away from the Exchange facility."
Where did you hear this viewmont?
Yes! You've nailed what this does --of those components, I've been taking astaxanthin for about a year (by itself) for glaucoma prevention. No side effects that I can discern.
Go GHSI!
Agree, should be fun tomorrow GLTA .
.60 + by pre-market tomorrow! IMO
Very doable and it probably will close .50 or above the way it's going.
30 more minutes left, can we close above .50 cents GO TIME .
Oh yes, I also read that they have good vision care products.
Starting Monday, NYSE will shut down and to trade only electronically.
Yes it looks like it. Which news did you find that from?
I think they have something for people infected with Coronavirus, check it out
The proprietary blend of the highly effective antioxidants, N-acetylcysteine, lipoic acid, and selenium, combined with the most powerful antioxidant in nature, astaxanthin, creates a targeted physiological network designed to enhance an effective interferon response to many types of viruses; interferon works through multiple pathways to suppress intracellular viral replication. At the same time, these agents exert anti-inflammatory effects that can help to prevent or control the excessive lung inflammation that can make some infections deadly.
Yes nice! .4750 now. Whatever is cooking, is cooking nicely!
We'll probably see a gap to .60 + in the morning?
Something is going on behind the scenes, GHSI is still climbing after hours, now to .4550
* * $GHSI Video Chart 03-18-2020 * *
Link to Video - click here to watch the technical chart video
They have good products. https://guardionhealth.com/
Trying to find out, in the meantime I bought/added to my position.
I haven't seen any new news today, so maybe the insiders and people who are close to insiders have some knowledge and are buying?
This was what they came up with previously.
Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula
Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system.
The formula will be a unique and exclusive brand of HWGB
San Diego, California, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc (“Guardion” or the “Company”) (Nasdaq:GHSI) announced that Ho Wah Genting Berhad (“HWGB”) a Malaysian company listed on the Malaysian Stock Exchange (Industrial Products sector) has selected Guardion to develop an immune- supportive formula for their consumer base. HWGB has contracted Guardion and its recently acquired subsidiary NutriGuard, to develop a proprietary formula to meet the demands of their customers for an immune-supportive product.
Professor Mark McCarty, the original founder of NutriGuard, and now a senior scientist consultant to Guardion, is a leader in the scientific validation of nutrition-based therapies for potentiating the type 1 interferon response to RNA viruses. Boosting type 1 interferon response is believed to blunt the replication of virus cells. Dr McCarty has been tasked with developing this proprietary formula for HWGB.
The formula is designed to provide both immuno-supportive and anti-inflammatory benefits to its users. The formula has not been used nor tested, nor is it intended to specifically address symptoms of the current COVID-19 virus.
Michael Favish, CEO of Guardion Health Sciences, stated “We are pleased to partner with Ho Wah Genting Berhad for the development of a product specifically designed to boost the immune system capability, i.e. type 1 interferon response, to RNA viruses.”
Dato’ Aaron Lim, group CEO for Ho Wah Genting Berhad, commented, “We are anxious to be able to deliver a unique product that can provide a timely and effective immune response to our customer base. I would like to thank Guardion Health Sciences for their assistance and responsiveness to this request and look forward to introducing this much needed product to the market.”
About Guardion Health Sciences, Inc.
Guardion is an ocular health sciences company thar develops, formulates, manufacture and distributes condition-specific medical foods supported by evidence-based protocols. Guardion’s initial medical food product, Lumega-Z, addresses a depleted macular protective pigment, a known risk factor for age-related macular degeneration (“AMD”) and a significant component of functional vision performance. Guardion has also developed a proprietary medical device, the MapcatSF®, which accurately measures the macular pigment density, therefore providing the only two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment. Information and risk factors with respect to Guardion and its business, including its ability to successfully develop and commercialize its proprietary products and technologies, may be obtained in the Company’s filings with the SEC at www.sec.gov.
About VectorVision®
VectorVision® specializes in the standardization of contrast sensitivity, glare sensitivity, low contrast acuity, and ETDRS acuity vision testing. Its patented standardization system provides the practitioner or researcher the ability to delineate very small changes in visual capability, either as compared to the population or from visit to visit. VectorVision®’s CSV-1000 device is considered the standard of care for clinical trials. VectorVision® is a wholly owned subsidiary of Guardion.
Guardion has completed development of the proprietary VectorVision® CSV-2000 standardized contrast sensitivity test and recently introduced the commercial product to the marketplace. The CSV-2000 is the only computer-generated vision testing instrument available that will provide the optical marketplace with the Company’s proprietary, industry-standard contrast sensitivity test, along with a full suite of standard vision testing protocols. The proprietary standardization methodology incorporated into the CSV-2000 includes a patented technology known as AcQviz that automatically and constantly measures and adjusts screen luminance to a fixed standard light level for vision testing.
About NutriGuard
NutriGuard formulates high-quality, scientifically credible nutraceuticals, which are designed to supplement consumers’ diets and assist in the prevention and management of an array of diseases and conditions. NutriGuard uses pharmaceutical standards to establish the safety and efficacy of the products it develops and markets, and also maintains that commitment through rigorous manufacturing and quality assurance programs. Guardion plans to increase NutriGuard’s existing customer base and build on its product platform by making NutriGuard products available to patients directly and through recommendations by their physicians.
It looks like a good product.
Important New Product Update
acuMMUNE: an Immunosupportive/Anti-Oxidant/Anti-Inflammatory Complex Available Soon
acuMMUNE is a unique nutraceutical formulation designed to support effective immune function – including in particular interferon-mediated anti-viral mechanisms – while also helping to quell the excessive lung inflammation that can lead to the harsh symptoms and even death associated with certain respiratory infections. Hence, acuMMUNE provides both immunosupportive and anti-inflammatory benefits.
The proprietary blend of the highly effective antioxidants, N-acetylcysteine, lipoic acid, and selenium, combined with the most powerful antioxidant in nature, astaxanthin, creates a targeted physiological network designed to enhance an effective interferon response to many types of viruses; interferon works through multiple pathways to suppress intracellular viral replication. At the same time, these agents exert anti-inflammatory effects that can help to prevent or control the excessive lung inflammation that can make some infections deadly.
Beta-Glucan, derived from the cell walls of brewer’s yeast, has been clinically proven to help stave off and control infections through enhancing the function of dendritic cells. These cells process antigens from infectious agents, which in turn recruit lymphocytes responsive to these antigens and create protective antibodies to eliminate virus-infected cells.
Zinc supplementation supports efficient multiplication of various immune cells, while also exerting protective anti-inflammatory effects. Several studies demonstrate that zinc supplementation can decrease infection risk in highly susceptible patients, such as young children and the elderly.
Followers
|
67
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1241
|
Created
|
05/30/19
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |